Joel Barbato, MD
Vascular Surgery · Saint Paul, MNNPI 1770663536
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $7,317 of the $9,421 with a category attached, or 77.7%. W. L. Gore & Associates, Inc. accounts for 82.4% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2024 at $6,248 and has fallen 76.3% since, to $1,479 in 2025.
Across 36 payments — averaging $261.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$8K
- Silk Road Medical, Inc.$791
- Medtronic$672
- Abbott$200
What the payments were for
- Travel & lodging$7,31778%
- Food & beverage$2,10422%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 23 | $7,758 |
| Silk Road Medical, Inc. | 4 | $791 |
| Medtronic(2 entities) | 7 | $672 |
| Abbott | 2 | $200 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GORE TAG Thoracic Endoprosthesis$5,633
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$1,166
- ENROUTE Transcarotid Neuroprotection System$759
- ENROUTE Transcarotid Stent System$759
- ENHANCE Transcarotid Peripheral Access Kit$759
- ENROUTE 0.014 Guidewire$759
- GORE TAG Thoracic Branch Endoprosthesis$422
- ENDURANT IIS$262
- EXCLUDER AAA Endoprosthesis$154
- Endurant$138
- GORE VIABAHN VBX Balloon Expandable Endo$129
- JETi Peripheral Catheter$105
How this compares
$9,421 in reported general payments places this provider in the 70th percentile of 84 vascular surgery providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 23 | $16,689 |
| Cilostazol | 119 | $3,416 |
| ClopidogrelClopidogrel Bisulfate | 237 | $2,856 |
| Oxycodone Hcl | 47 | $215 |
| Atorvastatin Calcium | 13 | $201 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 22 | $127 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Saint Paul
- Brian MillerSaint Paul$10K
- James DavisSaint Paul$5K
- Lan NguyenSaint Paul$2K
- Jodi GerdesSaint Paul$2K
- Todd RasmussenRochester$561K
- Matthew MelinRochester$196K
- Jesse ManungaMinneapolis$95K
- Joseph KaramMinneapolis$88K
- Derrick GreenMinneapolis$37K
- Fahad ShujaRochester$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.